Skip to content
Search

Latest Stories

Pharmacy majors reassure on steady supply of medicines

Leading pharmacy chains said they are taking steps to maintain safe and steady supply of medicines and healthcare services as COVID-19 crisis looms large over the UK.

As people are stocking up on painkillers and hand sanitisers pharmacies have seen a surge in customers, forcing many to ration supplies.


“You might have noticed that we’ve set a limit on the number of certain items you can buy. Thank you for supporting us and appreciating these limits as we try to help as many people as possible,” Seb James, Managing Director Boots UK said in a statement on Tuesday (17 March).

James said the chain continues to have stock in the supply chain of hand sanitisers and other high demand products like children’s medicine, pain relief and hygiene products. Hand sanitisers are being sent to stores each day to meet the “exceptional demand,” he added.

Boots will also offer free delivery of prescriptions for their NHS online repeat prescription service.

In a separate statement, James appealed to the public to desist from panic buying.

“We ask our customers to speak to our teams for ways they can proactively manage their prescriptions if they are in self isolation; and to only buy the medicines they need now so we can make sure as many people as possible can access the products they need,” he said.

Toby Anderson, chief executive of LloydsPharmacy parent McKesson UK, said the company has processes in place with suppliers and manufacturers to help minimise the impact of shortages and ensure a consistent supply of critical products.

“Our priority is to make sure that everyone has access to the medication that they need, when they need it, so we are doing everything we can to ensure availability, despite increasing demand and supply challenges,” he said in a statement on Tuesday.

Anderson informed that the company, which also has AAH Pharmaceuticals in its fold, will not be building additional stockholding within its supply chain, in line with the Department of Health and Social Care guidelines, to limit the risk of future potential medicine shortages.

“We will continue to monitor unusual downstream sales patterns, and we will act where needed to mitigate the risk of inappropriate bulk buying through effective product quota management,” he added.

Well Pharmacy has last week committed to holding the price of core lines where possible and introducing new competitively priced lines to meet the rising demand.

“We care for the health and wellbeing of our patients and customers and won’t seek to profiteer from this situation,” it said in a statement on Friday (13 March)

The chain has limited purchases of hand sanitiser in all its pharmacies to two per customer. The group also has pharmaceutical grade face masks available in store to meet the consumer requests.

Well said its supply chain network is coping well, with plenty of stock of key supplies.

More For You

Swizzels’ Easter range, including Squashies Drumchick and Sweet Shop Favourite tubs

PDA members will get the chance to vote from this week

Pic credit: iStock

PDA to inform its members to vote “no” in Royal College of Pharmacy proposals

A vote to create a potential Royal College of Pharmacy needs to be called off as the current proposals would lead to “irreversible change to the identity and purpose” of the sector’s professional leadership body, according to the Pharmacy Defence Association (PDA).

From March 13th to March 24th, The Royal Pharmaceutical Society’s members will take part in a Special Resolution Vote (SRV) which seeks to amend the Society’s Royal Charter to facilitate its transition to a Royal College and registered charity.

Keep ReadingShow less
Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less